Coccidioidomycosis and histoplasmosis in immunocompetent persons

JN Galgiani, CA Kauffman - New England Journal of Medicine, 2024 - Mass Medical Soc
Coccidioidomycosis and Histoplasmosis in Immunocompetent Persons | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

The next-generation DNA vaccine platforms and delivery systems: Advances, challenges and prospects

B Lu, JM Lim, B Yu, S Song, P Neeli… - Frontiers in …, 2024 - frontiersin.org
Vaccines have proven effective in the treatment and prevention of numerous diseases.
However, traditional attenuated and inactivated vaccines suffer from certain drawbacks such …

[HTML][HTML] Spherical nucleic acids-based nanoplatforms for tumor precision medicine and immunotherapy

S Liu, CY Yu, H Wei - Materials Today Bio, 2023 - Elsevier
Precise diagnosis and treatment of tumors currently still face considerable challenges due to
the development of highly degreed heterogeneity in the dynamic evolution of tumors. With …

Application of traditional vaccine development strategies to SARS-CoV-2

HM Rando, R Lordan, AJ Lee, A Naik, N Wellhausen… - Msystems, 2023 - Am Soc Microbiol
Over the past 150 years, vaccines have revolutionized the relationship between people and
disease. During the COVID-19 pandemic, technologies such as mRNA vaccines have …

Milk polar lipids: Untapped potential for pharmaceuticals and nutraceuticals

A Pawar, I Zabetakis, T Gavankar, R Lordan - PharmaNutrition, 2023 - Elsevier
Background Milk contains polar lipids may confer health benefits upon consumption.
Therefore, polar lipids have received considerable attention for development in the …

Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus vaccine in infants 6–7 months of age: A phase 1/2 randomized trial

X Sáez-Llorens, X Norero… - The Journal of …, 2024 - academic.oup.com
Background Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract
infections in infants. This phase 1/2, observer-blind, randomized, controlled study assessed …

[PDF][PDF] Materials Today Bio

S Liu, Y Li, J Zhang, H Zhang, Y Wang, C Chuah… - scienceopen.com
Overall, 12% of the global population (800 million) suffers from liver disease, which causes 2
million deaths every year. Liver injury involving characteristic reactive oxygen/nitrogen …